Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
Iridex (Nasdaq: IRIX) will present at the Planet MicroCap Las Vegas 2026 Conference.
Rhea-AI Summary
Iridex (Nasdaq: IRIX) will present at the Planet MicroCap Las Vegas 2026 Conference. Management is scheduled to present on Wednesday, June 17, 2026 at 4:00 pm PT.
A live and archived webcast will be available via the Event Calendar in the Investors section of the company website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – IRIX
In the Jun 10 session, IRIX gained 0.89%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- June 17, 2026
- Planet MicroCap Las Vegas 2026 presentation date
- Presentation time
- 4:00 pm PT
- Scheduled time for conference presentation
- Current price
- $1.11
- Pre-conference close price
- 52-week high
- $1.6481
- Upper end of 52-week range
- 52-week low
- $0.8688
- Lower end of 52-week range
- Market cap
- $19,321,235
- Equity value prior to conference news
- Today’s volume
- 11,602 shares
- Trading volume prior to news release
- 20-day avg volume
- 72,293 shares
- Average daily volume benchmark
Historical Context
-
Flat revenue with margin pressure but narrowed net loss and reaffirmed guidance.
-
Announcement of Q1 2026 release date and conference call logistics.
-
New EyeProGPO partnership to expand access to retina laser technology.
-
Double-digit Q4 growth, FY 2025 revenue up and adjusted EBITDA turning positive.
-
Scheduling of Q4 and full-year 2025 results and accompanying conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.
Management is scheduled to present on Wednesday, June 17 at 4:00 pm PT. Interested parties may access a live and archived webcast of the presentation on the “Event Calendar” page of the “Investors” section of the company’s website at www.IRIDEX.com.
About Iridex Corporation
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers a differentiated laser treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma and diabetic macular edema (DME) and other retinal diseases. Iridex products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For further information, visit the Iridex website at www.iridex.com.
MicroPulse® is a registered trademark of Iridex Corporation, Inc. in the United States, Europe and other jurisdictions. © 2026 Iridex Corporation. All rights reserved.
Investor Relations Contact
Philip Taylor
Gilmartin Group
investors@iridex.com
Media Contact
Joan Stauffer
jstauffer@iridex.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.